Evaluation of the Use and Cost of Psychotropic Drugs in BPJS Schizophrenia Patients Using the ATC/DDD & DU 90% Method at Dr. Loekmono Hadi Kudus Regional Hospital
Main Article Content
Abstract
Abstract. People with Mental Disorders (ODGJ) are people who experience disorders of thinking, behavior, and emotions that are manifested in a series of symptoms or significant changes that include behavior and can cause suffering and obstacles in carrying out people's functions as human beings. Schizophrenia is one of the most complex and challenging of mental disorders. Schizophrenia is a heterogeneous syndrome that is irregular and behavioral disorders strange behavior, delusions, hallucinations, inappropriate emotions, and disorders of major psychosocial functions. Someone who experiences mental health disorders can be treated by administering psychotropic drugs. This study aims to determine the pattern of use and costs of psychotropic drugs in BPJS schizophrenia inpatients with the ATC/DDD and DU 90% methods at Dr. Loekmono Hadi Kudus Regional Hospital for the period January-December 2023. This study uses a quantitative method with a non-experimental descriptive design, whose data is taken retrospectively using secondary data in the form of medical records of schizophrenia patients. The sampling technique used is Total Purposive Sampling. Psychotropic use data was calculated using the formula DDD/100 days of care and DU 90%. The results showed that there were 213 medical records of schizophrenia patients who met the inclusion criteria with the number of male gender of 153 patients (71.83%), the most age was adult (26-45 years) 139 patients (65.26%), the average LOS was 14 to 15 days with a total LOS of 2981 days, the use of psychotropics with the highest value was risperidone at 38.05 DDD/100 days of care. Psychotropic drugs included in the 90% DU segment include risperidone (20.68%), olanzapine (15.86%), chlorpromazine (14.17%), trihexyphenidyl (12.68%), fluoxetine (6.16%), sertraline (5.69%), haloperidol (5.64%), lithium (3.22%), aripiprazole (2.49%), trifluoperazine (2.38%), and clozapine (2.35%). The highest cost of psychotropic drugs is aripiprazole 10 mg, with a total cost of Rp 3,444,000 for one year, with a total of 205 tablets used.
Downloads
Article Details
References
Abdulah, AZ, Suerni, T. & Nurochmah, E. (2023). Mental Health Problems of Generation Z in Mental Hospitals. Journal of Mental Health Nursing (JKJ): Indonesian National Nurses Association, 11(2):267–72.
Amalia, I., Wilson, & Hermawati, E. (2022). The Relationship between Characteristics of Schizophrenia Patients and Relapse Rates at the Sungai Bangkong Regional Mental Hospital, Pontianak. Cerebellum Journal, 8(2):1–6.
Blessing, IO, GBS, I., George, E.O., Okajie, F.O. & Solomon, AO (2013). Effect of Chlorpromazine and Haloperidol Combination on Lipid Profile in Nigerian Schizophrenic Patients. Biochimica Clinica, 37(12):S263.
Burns, MAC, Wells, BG, Schwinghammer, TL, Malone, PM, Kolesar, JM, Rotschafer JC & Dipiro, JT (2016). Pharmacotherapy Principles & Practice. The Mc-Graw-Hill Companies: United States.
Ministry of Health of the Republic of Indonesia. (2006). Guidelines for the Implementation and Procedures of Indonesian Hospital Medical Records, Revision II. Jakarta: Ministry of Health of the Republic of Indonesia.
Dewi, S., Elvira, SD & Budiman, R. (2013). Overview of the Life Needs of People with Schizophrenia. J Indon Med Assoc, 63(3): 84-90.
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G. & Posey LM (2008). Pharmacotherapy a Pathophysiology Approach Seventh Edition. Vol. 53. The Mc-Graw-Hill: United States.
Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., & Dipiro, CV (2015). Pharmacotherapy Handbook Ninth Edition-Section 13. The Mc-Graw-Hill Education: United States.
Elvira, SD & Hadisukanto, G. (2017). Textbook of Psychiatry, 3rd Edition. Jakarta: Publishing Board of the Faculty of Medicine, University of Indonesia.
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O. & Tran, N. (2017). Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Management of Schizophrenia and Related Disorders. Australian and New Zealand Journal of Psychiatry, 51(3):289–90.
Griffin, C.E., Kaye, FraA.M., Bueno, F.R. & Kaye, A.D. (2013). Benzodiazepine Pharmacology and Central Nervous System-Mediated Effects. Ochsner Journal, 13(2):214–23.
Ikawati, Z. (2014). Pharmacotherapy of Central Nervous System Diseases. Yogyakarta: Bursa Ilmu. Ministry
Ministry of Health of the Republic of Indonesia. (2017). Technical Guidelines for Evaluation of Drug Use in Health Facilities. Jakarta: Ministry of Health of the Republic of Indonesia.
Kulkarni D., N, KB, Sahu, SK & G, RK (2016). Drug Utilization 90%: An Innovative Method in Assessing Quality of Drug Prescription with Specific Reference to Non-Steroidal Anti-Inflammatory Drugs Prescription. International Journal of Basic and Clinical Pharmacology, 5(5):1746–51.
Li, R., Ma, X., Wang, G., Yang, J. &. Wang C. (2017). Why Sex Differences in Schizophrenia. Physiology & Behavior, 176(5):139–48.
Litama, K., Robiyanto, & Susanti, R. (2019). Characteristics of Psychiatric Drug Therapy Classes in Adolescent Patients at Sungai Bangkong Regional Mental Hospital, Pontianak, 2018-2019. International Applied Biology, 3(1): 81-87.
Nababan ED, Kamariyah, Yuliana. (2023). Overview of Family Support for Mentally Ill Patients at the Mental Health Polyclinic of Jambi Province Mental Hospital. Pinang Masak Nursing Journal, 2:23–37.
NIPH (Norwegian Institute of Public Health). (2022). Guidelines for ATC classification and DDD assignment 2023. Oslo Norway: Norwegian Institute of Public Health.
Nofriyanto, A. (2019). The Relationship between Psychological Characteristics of Gender and the Frequency of Relapse in Schizophrenia Patients at the Grhasia Mental Hospital Polyclinic in Yogyakarta. 'Aisyiyah University, 2(1):1–11.
Nuryati. (2017). Medical Records and Health Information Teaching Materials. Jakarta: Ministry of Health of the Republic of Indonesia.
Presidential Regulation of the Republic of Indonesia. (2018). Presidential Regulation of the Republic of Indonesia Number 82 of 2018 Concerning National Health Insurance. Jakarta: Presidential Regulation of the Republic of Indonesia.
Pratiwi, Y., Asro, IK, Wildayanti, Pratitis, MP, Rahmawaty, A. & Tunggadewi, AP (2024). Evaluation of the Use and Cost of Oral Antidiabetic Drugs in the Referral Program Using the ATC/DDD & DU 90% Method at Sana Farma Pharmacy, Kudus Regency. Cendekia Journal of Pharmacy, 8(2):145–61.
Purwandityo, AG, Febrianti, Y., Sari, CP, Ningrum, VDA & Sugiyarto, OP (2018). The Effect of Antipsychotics on Reducing the Score of the Positive and Negative Syndrome Scale-Excited Component. Indonesian Journal of Clinical Pharmacy, 7(1):19–29.
Basic Health Research. (2018). National Report on RISKESDAS 2018. Jakarta: Health Research and Development Agency, Ministry of the Republic of Indonesia.
Stockley. (2009). Stockley's Drug Interactions.” Analytical Biochemistry, 11(1):1–5.
Aditya, M. & Yoedistira, CD (2021). The Effect of Combination Antipsychotic Therapy on Depression Levels in Schizophrenia Patients at the Talun Community Health Center, Blitar Regency.” Sainsbertek Scientific Journal of Science & Technology 2(1):201–7.
Law of the Republic of Indonesia. (2009). Law of the Republic of Indonesia Number 36 of 2009 concerning Health. Jakarta: Law of the Republic of Indonesia.
Law of the Republic of Indonesia. (2014). Law of the Republic of Indonesia Number 18 of 2014 concerning Mental Health. Jakarta: Law of the Republic of Indonesia.
Vinkers, CH, Tijdink, JK, Luykx, JJ & Vis R. (2012). Kiezen Voor de Juiste Benzodiazepine. Nederlands Tijdschrift Voor Geneeskunde, 156(35):1–7.
WHO (World Health Organization). (2024). Guidelines for ATC Classification and DDD Assignment. Oslo: Norwegian Institute of Public Health.
Yulianty, MD, Cahaya, N. & Srikartika. VM (2017). Study of Antipsychotic Use and Side Effects in Schizophrenia Patients at Sambang Lihum Mental Hospital, South Kalimantan. Journal of Pharmaceutical & Clinical Sciences, 3(2):153.
Zahnia, S. & Sumekar, DW (2016). Epidemiological Study of Schizophrenia. Majority, 5(4). 160-166.